Comparison of Outcomes Between Radical Nephrectomy and Partial Nephrectomy in Clinical T2 Renal Cell Carcinoma: A Retrospective Korean Renal Cell Carcinoma Cohort Study

• Published in: Journal of Urologic Oncology Vol. 22; no. 2; pp. 136 - 143
• Main Authors: Chung, Younsoo, Byun, Seok-Soo, Hong, Sung Kyu, Lee, Sangchul, Jeong, Chang Wook, Kang, Seok Ho, Hong, Sung-Hoo, Lee, Ji Youl, Kim, Yong-June, Chung, Jinsoo, Hwang, Eu Chang, Kwon, Tae Gyun, Kim, Jung Kwon
• Format: Journal Article
• Language: English
• Published: Korean Urological Oncology Society 01.07.2024; 대한비뇨기종양학회
• Subjects: chronic renal insufficiency; nephrectomy; renal cell carcinoma; 비뇨기과학
• ISSN: 2951-603X; 2982-7043; 2982-7043
• DOI: 10.22465/juo.244800360018

Purpose: We compared the surgical outcomes of radical nephrectomy (RN) and partial nephrectomy (PN) in adult patients with clinical T2 stage (cT2) renal cell carcinoma (RCC) by utilizing data from the Korean Renal Cell Carcinoma (KORCC) database.Materials and Methods: We retrospectively analyzed adult patients with cT2 RCC from 8 tertiary hospitals who were registered in the KORCC between 2003 and 2023. Patients with a solitary kidney or bilateral tumors were excluded. The patient cohort was divided into RN and PN arms, and propensity score matching (PSM) was conducted with a 1:3 ratio. Perioperative and survival outcomes were compared between arms.Results: After PSM, the PN and RN arms included 44 and 132 patients, respectively. No significant differences were observed in baseline characteristics, apart from laterality, following PSM. Regarding perioperative outcomes, complications of Clavien-Dindo classification grade III or higher (11.4%, p<0.001) and urological complications (9.1%, p=0.045) were more common in the PN arm than in the RN arm. Postoperative renal function was superior in the PN arm, whereas the incidence of de novo chronic kidney disease (CKD) at 6 months was higher among the recipients of RN (37.6%, p<0.001). Pathological examination indicated a higher pathological T stage in the RN arm. Overall, cancer-specific, and recurrence-free survival rates did not differ significantly between arms. Based on Cox regression analysis, the use of PN was not a significant predictor of recurrence-free survival (hazard ratio, 0.675; p=0.474).Conclusions: In cT2 RCC, PN was associated with a lower incidence of de novo CKD than RN. No significant differences in survival outcomes were noted. PN may represent a viable alternative to RN for certain patients with cT2 RCC. Further research is warranted to explore the management of advanced RCC.